As of 2026-10-05, the Relative Valuation of Prelude Therapeutics Inc (PRLD) is (20.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.67 USD, the upside of Prelude Therapeutics Inc based on Relative Valuation is -662.8%.
The range of the Relative Valuation is (18.99) - (22.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 29.1x | 27.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (18.99) - (22.10) | (20.66) |
| Upside | -617.3% - -702.2% | -662.8% |
| Date | P/E |
| 2026-10-02 | -4.83 |
| 2026-10-01 | -4.99 |
| 2026-09-30 | -5.15 |
| 2026-09-29 | -5.21 |
| 2026-09-28 | -5.15 |
| 2026-09-25 | -5.10 |
| 2026-09-24 | -5.25 |
| 2026-09-23 | -5.68 |
| 2026-09-22 | -6.39 |
| 2026-09-21 | -6.19 |
| 2026-09-18 | -6.41 |
| 2026-09-17 | -6.02 |
| 2026-09-16 | -5.89 |
| 2026-09-15 | -5.95 |
| 2026-09-14 | -6.04 |
| 2026-09-11 | -6.04 |
| 2026-09-10 | -6.15 |
| 2026-09-09 | -6.70 |
| 2026-09-08 | -6.98 |
| 2026-09-04 | -7.19 |
| 2026-09-03 | -6.91 |
| 2026-09-02 | -7.15 |
| 2026-09-01 | -7.23 |
| 2026-08-31 | -7.37 |
| 2026-08-28 | -7.20 |
| 2026-08-27 | -8.35 |
| 2026-08-26 | -8.64 |
| 2026-08-25 | -8.68 |
| 2026-08-24 | -8.52 |
| 2026-08-21 | -8.73 |
| 2026-08-20 | -8.56 |
| 2026-08-19 | -7.61 |
| 2026-08-18 | -7.57 |
| 2026-08-17 | -7.41 |
| 2026-08-14 | -7.31 |
| 2026-08-13 | -7.06 |
| 2026-08-12 | -7.55 |
| 2026-08-11 | -7.01 |
| 2026-08-10 | -6.36 |
| 2026-08-07 | -6.45 |
| 2026-08-06 | -6.16 |
| 2026-08-05 | -5.98 |
| 2026-08-04 | -5.95 |
| 2026-08-03 | -5.78 |
| 2026-07-31 | -6.06 |
| 2026-07-30 | -6.65 |
| 2026-07-29 | -6.20 |
| 2026-07-28 | -6.11 |
| 2026-07-27 | -5.12 |
| 2026-07-24 | -5.04 |